Mitochondria-targeted esculetin

Intervention1 paper4 findings

  • Animals1

Outcomes

4

p38 MAPK signalling

downin mouse cells1Very low certainty

1 study
  1. Mitochondria-targeted esculetin inhibits p38 MAPK signalling in mouse cells.

    Cellsin H9c2 cardiomyocytes and primary adult mouse cardiac fibroblasts

    Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026

p38 MAPK signalling →

AMPK signalling

upin mouse cells1Very low certainty

1 study
  1. Mitochondria-targeted esculetin activates AMPK signalling in mouse cells.

    Cellsin H9c2 cardiomyocytes and primary adult mouse cardiac fibroblasts

    Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026

AMPK signalling →

Fibrosis

downin mice1Very low certainty

1 study
  1. Mitochondria-targeted esculetin decreases fibrosis in mice.

    Animalsaged Apoe-/- mice

    Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026

Cardiac hypertrophy

downin mice1Very low certainty

1 study
  1. Mitochondria-targeted esculetin decreases cardiac hypertrophy in mice.

    Animalsaged Apoe-/- mice

    Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling · Biochemical and biophysical research communications · 10 Sep 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01